Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Delcath Systems Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
DCTH
Nasdaq
3841
https://delcath.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Delcath Systems Inc
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Apr 4th, 2024 12:35 pm
Delcath Systems Inc (DCTH) Reports Mixed Year-End Financials Amidst Strategic Advancements
- Mar 26th, 2024 1:12 pm
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
- Mar 26th, 2024 11:30 am
Insiders of Delcath Systems Getting Good Value On Their US$736.5k Investment
- Mar 23rd, 2024 12:52 pm
Delcath Systems Closes $7 Million Private Placement
- Mar 20th, 2024 12:15 pm
Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call
- Mar 19th, 2024 1:00 pm
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer
- Mar 18th, 2024 9:20 pm
Delcath Systems Announces $7 Million Private Placement
- Mar 15th, 2024 12:20 pm
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 8th, 2024 10:00 pm
Delcath Systems to Participate in Upcoming Investor Conferences
- Mar 8th, 2024 2:00 pm
Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)
- Feb 22nd, 2024 10:00 pm
Retail investors account for 52% of Delcath Systems, Inc.'s (NASDAQ:DCTH) ownership, while institutions account for 40%
- Feb 15th, 2024 2:30 pm
Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024
- Jan 31st, 2024 1:00 pm
Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
- Jan 23rd, 2024 1:00 pm
Delcath Systems, Inc. (NASDAQ:DCTH): Are Analysts Optimistic?
- Jan 19th, 2024 2:14 pm
Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™
- Jan 16th, 2024 1:00 pm
Insider Buying: Chief Medical Officer Vojo Vukovic Acquires 40,000 Shares of Delcath Systems ...
- Dec 15th, 2023 6:02 pm
Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research
- Dec 7th, 2023 2:00 pm
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Nov 15th, 2023 10:00 pm
Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update
- Nov 13th, 2023 9:05 pm
Scroll